City

Boston (1)

Iowa City (1)

Lexington (1)

Rochester (1)

Overall Status

Completed (1)

Not yet recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 2 (2)

phase 1/phase 2 (1)

Sponsor

Dana-Farber Cancer Institute (1)

Lowell Anthony, MD (1)

Viewpoint Molecular Targeting (1)

Collaborator

Bristol-Myers Squibb (1)

Entrinsic Bioscience Inc. (1)

Exelixis (1)

Intervention

[212pb]vmt-α-net, (1)

amino acid based medical food/drink (1)

cabozantinib (1)

nivolumab (1)

Study Documents

Intervention Type

drug (2)

dietary supplement (1)

Funder Type

Other (2)

Industry (1)

Study Type

Interventional (3)

carcinoid tumor of gi system

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Neuroendocrine Tumors, Neuroendocrine Tumor of the Lung, Neuroendocrine Tumor of Pancreas Trial in Iowa City, Rochester

Not yet recruiting

Neuroendocrine Tumors
+8 more

[212Pb]VMT-α-NET,

Iowa City, Iowa
+1 more

Nov 23, 2022

Neuroendocrine Tumors, Carcinoid Tumor of GI System, Diarrhea Trial in Lexington (Amino Acid Based Medical Food/Drink)

Completed

Neuroendocrine Tumors
+3 more

Amino Acid Based Medical Food/Drink

Lexington, Kentucky

University of Kentucky Markey Cancer Center

Nov 2, 2022

Carcinoid Tumor, Carcinoid Tumor of GI System, Neuroendocrine Tumors Trial in Boston (Nivolumab, Cabozantinib)

Recruiting

Carcinoid Tumor
+2 more

Boston, Massachusetts
+1 more

Jan 14, 2022